Clinical trials
Phase 1 Vascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 5 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Seagen Inc. | 2 |
| AO GENERIUM | 1 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Antidote Therapeutics, Inc | 1 |
| Biosense Webster, Inc. | 1 |
| Celularity Incorporated | 1 |
| Indiana University | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Kelonia Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 29 |
| Cardiovascular Diseases | 15 |
| Hematologic Diseases | 7 |
| Immunoproliferative Disorders | 6 |
| Lymphoproliferative Disorders | 6 |
| Multiple Myeloma | 6 |
| Paraproteinemias | 6 |
| Hemorrhagic Disorders | 5 |
| Hemostatic Disorders | 5 |
| Immune System Diseases | 5 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.